Regal Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,514
Closed -$1.96M 54
2024
Q1
$1.96M Sell
2,514
-2,724
-52% -$1.94M 0.2% 30
2023
Q4
$3.05M Buy
5,238
+38
+0.7% +$22.2K 0.32% 30
2023
Q3
$2.79M Sell
5,200
-5,700
-52% -$2.94M 0.62% 27
2023
Q2
$5.11M Buy
+10,900
New +$4.57M 1.11% 17

Other funds holding LLY

Regal Partners's LLY Position: Q2 2024 in Review

Regal Partners sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 2,514 shares — an estimated $1.96M sold.

Regal Partners first reported a position in LLY in Q2 2023 and held it in 4 quarters. The position peaked at $5.11M in Q2 2023. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Regal Partners reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Regal Partners sold 2,514 Eli Lilly shares in Q2 2024, an estimated $1.96M.
  • Regal Partners first reported a position in Eli Lilly in Q2 2023 and held it in 4 quarters.
  • Regal Partners's Eli Lilly position peaked at $5.11M in Q2 2023.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Regal Partners's 13F filing for Q2 2024, filed 2 Aug 2024.